Nouveau Life Pharmaceuticals Inc
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in providing a platform for remote senior care. The company also enables users to monitor patients in real time and access detailed patient information digitally; and its platform is designed to detect emergencies proactively and facilitate non-face-to-face care services. In addition, the company is developing robotic and ar… Read more
Nouveau Life Pharmaceuticals Inc (NOUV) - Total Assets
Latest total assets as of March 2023: $7.71K USD
Based on the latest financial reports, Nouveau Life Pharmaceuticals Inc (NOUV) holds total assets worth $7.71K USD as of March 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nouveau Life Pharmaceuticals Inc - Total Assets Trend (2002–2006)
This chart illustrates how Nouveau Life Pharmaceuticals Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nouveau Life Pharmaceuticals Inc - Asset Composition Analysis
Current Asset Composition (December 2006)
Nouveau Life Pharmaceuticals Inc's total assets of $7.71K consist of 0.3% current assets and 99.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $820.60K | 61.7% |
| Intangible Assets | $505.78K | 38.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2002–2006)
This chart illustrates how Nouveau Life Pharmaceuticals Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nouveau Life Pharmaceuticals Inc's current assets represent 0.3% of total assets in 2006, a decrease from 100.0% in 2002.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2006, down from 100.0% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 38.0% of total assets, an increase from 0.0% in 2002.
- Asset Diversification: The largest asset category is property, plant & equipment at 61.7% of total assets.
Nouveau Life Pharmaceuticals Inc Competitors by Total Assets
Key competitors of Nouveau Life Pharmaceuticals Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Nouveau Life Pharmaceuticals Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Nouveau Life Pharmaceuticals Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Nouveau Life Pharmaceuticals Inc is currently not profitable relative to its asset base.
Nouveau Life Pharmaceuticals Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.25 | 0.02 | 0.00 |
| Quick Ratio | 4.25 | 0.02 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.90K | $ -29.64K | $ -631.31K |
Nouveau Life Pharmaceuticals Inc - Advanced Valuation Insights
This section examines the relationship between Nouveau Life Pharmaceuticals Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 22.72 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 4482.2% |
| Total Assets | $1.33 Million |
| Market Capitalization | $0.94 USD |
Valuation Analysis
Below Book Valuation: The market values Nouveau Life Pharmaceuticals Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Nouveau Life Pharmaceuticals Inc's assets grew by 4482.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Nouveau Life Pharmaceuticals Inc (2002–2006)
The table below shows the annual total assets of Nouveau Life Pharmaceuticals Inc from 2002 to 2006.
| Year | Total Assets | Change |
|---|---|---|
| 2006-12-31 | $1.33 Million | +4482.20% |
| 2005-12-31 | $29.03K | +2969.03% |
| 2004-12-31 | $946.00 | -88.04% |
| 2003-12-31 | $7.91K | +534.08% |
| 2002-12-31 | $1.25K | -- |